1. Home
  2. MDAI vs CLNN Comparison

MDAI vs CLNN Comparison

Compare MDAI & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.41

Market Cap

48.8M

Sector

Health Care

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.03

Market Cap

48.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDAI
CLNN
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
48.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MDAI
CLNN
Price
$1.41
$5.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$3.25
$32.67
AVG Volume (30 Days)
215.5K
62.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$82.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$2.28
52 Week High
$3.21
$13.50

Technical Indicators

Market Signals
Indicator
MDAI
CLNN
Relative Strength Index (RSI) 39.75 54.55
Support Level $1.32 $3.43
Resistance Level $1.76 $5.71
Average True Range (ATR) 0.07 0.43
MACD -0.01 0.13
Stochastic Oscillator 29.17 76.74

Price Performance

Historical Comparison
MDAI
CLNN

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: